Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich-Fibrin Gel in Chronic Leg Ulcers
NCT07294521Phase 1Recruiting
- Sponsor
- Pak Emirates Military Hospital
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of platelet rich fibrin in leg ulcer, sponsored by Pak Emirates Military Hospital. Primary endpoint: 50% improvement in Bates Jensen wound assessment tool (BWAT) score at 1 month. Started Dec 2025; status: recruiting.
02
Drugs
platelet rich fibrin
03
Conditions
leg ulcer
Beyond the preview
Go deeper on NCT07294521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07294521.